Annual Lung Cancer SPORE Meeting
The Annual Lung Cancer SPORE Meeting will be hosted by MD Anderson Cancer Center and co-host the University of Texas Southwestern as the University of Texas Lung Cancer SPORE, led by MPIs John Heymach, M.D., Ph.D., and John Minna, M.D.
This hybrid meeting encourages collaborations between clinical and scientific investigators and will continue the tradition of reporting on the latest developments in lung cancer translational research.
We look forward to a robust and collaborative meeting.
June 10–11, 2025
The meeting will take place in Houston, Texas, and virtually via Zoom.
Registration closes June 2, 2025.
Abstracts
The agenda will be based on submitted abstracts associated with each session. Abstract submissions will be reviewed by the scientific committee to decide whether the abstract will be presented orally or by poster presentation. Selected abstracts or posters will require in-person attendance. Tentatively, the SPORE meeting will focus on these themes of particular interest:
- Theme 1: Tailoring Immunotherapy
- Theme 2: Pre-malignancies/Early Detection and Screening
- Theme 3: Small Cell Lung Cancer
- Theme 4: Radiomics/Artificial Intelligence
- Theme 5: Vaccines and Cellular Therapies
- Theme 6: Oncogene-driven lung cancers and resistance to targeted therapies
- Theme 7: CNS Metastasis
- Theme 8: Health Disparities in Lung Cancer
- Theme 9: Cancer Biology
Submit an Abstract
Abstract submissions are due by April 4, 2025 at 3 p.m. ET.
Location
In-Person:
MD Anderson Cancer Center
Onstead Auditorium
6767 Bertner Avenue
Houston, TX, 77030
Virtual:
A Zoom link will be sent to registered attendees.
Hotel Accommodations
Hotel Zaza Museum District
5701 Main St.
Houston, TX, 77005
Block rate: $219 per night
Cutoff Date: May 30, 2025
CODE: MDA609
How to get to the venue from the hotel
There will be a shuttle bus (approx. 15 min ride) between the Hotel Zaza Museum District and the meeting venue. It will leave the hotel for Onstead Auditorium at 7:15 a.m. and will leave Onstead Auditorium for the hotel at 5:30 p.m.
Participants may also take the Metrorail (red line), which leaves every 10 minutes, from the “Museum District” to “Dryden TMC” train stations.
Scientific Committee
MD Anderson Cancer Center will be this year’s host of the annual Lung Cancer SPORE Meeting. The Scientific Committee includes clinicians, scientists and advocates representing the Lung SPORE community. They are tasked with setting the agenda and the selection of abstracts to be presented in-person and via posters.
John Heymach, M.D., Ph.D.
Professor & Department Chair
David Bruton, Jr Chair in Cancer Research
MPI University of Texas Lung SPORE
Thoracic/Head & Neck Medical Oncology
MD Anderson
Don Gibbons, M.D., Ph.D.
Professor & Deputy Department Chair
Thoracic/Head & Neck Medical Oncology
MD Anderson
Lauren Byers, M.D.
Professor & Thoracic Section Chief
Thoracic/Head & Neck Medical Oncology
MD Anderson
Jianjun Zhang, M.D., Ph.D.
Professor
Thoracic/Head & Neck Medical Oncology
MD Anderson
John Minna, M.D.
Director, Hamon Center for Therapeutic Oncology Research
Sarah M. & Charles E. Seay Distinguished Chair in Cancer Research
Professor, Pharmacology and Internal Medicine
Max L. Thomas Distinguished Chair in Molecular Pulmonary Oncology
MPI University of Texas Lung SPORE
University of Texas Southwestern Medical Center
David Gerber, M.D.
Professor
Co-PI University of Texas Lung SPORE
Internal Medicine
University of Texas Southwestern Medical Center
Kathryn O’Donnell, Ph.D.
Associate Professor
Department of Molecular Biology
Co-leader, Development and Cancer Program, Simmons Comprehensive Cancer Center
University of Texas Southwestern Medical Center
Peter Ujhazy, M.D., Ph.D.
Deputy Associate Director
Translational Research Program
Division of Cancer Treatment and Diagnosis, National Cancer Institute
Organizing Committee
Robert Cardnell
Research Group Leader
Thoracic/Head & Neck Medical Oncology
MD Anderson
LaShae Morris
Administrative Director
Thoracic/Head & Neck Medical Oncology
MD Anderson
Demetria Babineaux
Operations Manager
Thoracic/Head & Neck Medical Oncology
MD Anderson
Questions?
Questions about the agenda should be directed to John Heymach, M.D., Ph.D., and Don Gibbons, M.D., Ph.D.
Questions about meeting logistics, registration or abstract submissions should be directed to Robert Cardnell, Ph.D., and LaShae Morris, M.H.A.